Concerns rise among Korean drug makers

The domestic pharmaceutical sector is expected to face an inevitable blow as a court ruled that the Health Insurance Review and Assessment Service should make public the actually trade prices of 20 medicines in 35 hospitals.

Some are raising concerns that such a disposal may cause turmoil in Korea's pharmaceutical pricing system.

In order to ensure transparency of drug prices, the govern...